Alimentary lipemia enhances the membrane expression of platelet P- selectin without affecting other markers of platelet activation

Atherosclerosis

Volumn 137, Issue 1, 1998, Pages 107-113

  Bröijersén, Anders ^a   Karpe, Fredrik ^b   Hamsten, Anders ^b   Goodall, Alison H ^c   Hjemdahl, Paul ^a  

^a Division of Clinical Immunology   (Sweden)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Dept of Chem Pathol Hum M   (United Kingdom)

Author keywords

Thromboglobulin; Alimentary lipemia; Filtragometry; Flow cytometry; P selectin; Platelet factor 4; Platelets

Indexed keywords

ADENOSINE DIPHOSPHATE; APOLIPOPROTEIN B100; APOLIPOPROTEIN B48; BETA THROMBOGLOBULIN; FIBRINOGEN; PADGEM PROTEIN; THROMBOCYTE FACTOR 4; TRIACYLGLYCEROL;

ADULT; ARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HYPERLIPIDEMIA; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; POSTPRANDIAL STATE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE AGGREGATION; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; APOLIPOPROTEINS B; BETA-THROMBOGLOBULIN; BIOLOGICAL MARKERS; BLOOD PLATELETS; CELL MEMBRANE; DATA INTERPRETATION, STATISTICAL; DIET, ATHEROGENIC; DIETARY FATS; HUMANS; HYPERLIPIDEMIAS; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS; MALE; P-SELECTIN; PLATELET ACTIVATION; PLATELET FACTOR 4; POSTPRANDIAL PERIOD; TIME FACTORS; TRIGLYCERIDES;

EID: 0032478155     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(97)00260-8     Document Type: Article

References (44)

1. Simpson HS, Williamson CM, Olivecrona T et al. Postprandial lipemia, fenofibrate and coronary artery disease. Atherosclerosis. 85:1990;193-202.
2. Groot PHE, van Stiphout WAHJ, Krauss XH et al. Postprandial lipoprotein metabolism in normolipidemic men with and without coronary artery disease. Arterioscler Thromb. 11:1991;653-662.
3. Patsch JR, Miesenbyck G, Hopferwieser T et al. Relation of triglyceride metabolism and coronary artery disease. Studies in the postprandial state. Arterioscler Thromb. 12:1992;1336-1345.
4. Karpe F, Steiner G, Uffelman K, Olivecrona T, Hamsten A. Postprandial lipoproteins and progression of coronary atherosclerosis. Atherosclerosis. 106:1994;83-97.
5. Zilversmit DB. Atherogenesis: A postprandial phenomenon. Circulation. 60:1979;473-485.
6. Karpe F, Hamsten A. Postprandial lipoprotein metabolism and atherosclerosis. Curr Opin Lipidol. 6:1995;123-129.
7. Silveira A, Karpe F, Blombäck M, Steiner G, Walldius G, Hamsten A. Activation of coagulation factor VII during alimentary lipemia. Arterioscler Thromb. 14:1994;60-69.
8. Nordøy A, Strøm E, Gjesdal K. The effect of alimentary hyperlipaemia and primary hypertriglyceridaemia on platelets in man. Scand. J. Haematology. 12:1974;329-340.
9. O'Brien JR, Etherington MD, Jamieson S. Acute platelet changes after large meals of saturated and unsaturated fats. Lancet. 1:1976;878-880.
10. Lowe GDO, Johnston RV, Drummond MM, Forbes CD, Prentice CRM. Induction of circulating platelet-aggregates in healthy subjects by a saturated fat meal. Thromb Res. 16:1979;565-568.
11. Johnston RV, Giner JV, Lowe GDO, Forbes CD, Prentice CRM. Prevention of lipid induced platelet aggregation by aspirin. Thromb Res. 27:1982;235-239.
12. Nordøy A, Lagarde M, Renaud S. Platelets during alimentary hyperlipaemia induced by cream and cod liver oil. Eur J Clin Invest. 14:1984;339-345.
13. Fuhrman B, Brook JG, Aviram M. Increased platelet aggregation during alimentary hyperlipemia in normal and hypertriglyceridemic subjects. Ann Nutr Metab. 30:1986;250-260.
14. Jakubowski JA, Ardlie NG, Chesterman CN, McGready JF, Morgan FJ. Acute postprandial lipaemia does not influence the in vivo activity of human platelets. Thromb Res. 39:1985;725-732.
15. Belch JJF, Sanibadi AR, McLaughlin K, Forbes CD. Platelet changes after a satured fat meal and their prevention by dazmegrel, a thromboxane synthetase inhibitor. Lipids. 22:1987;159-162.
16. Salomaa V, Rasi V, Pekkanen J et al. The effects of saturated fat and n-6 polyunsaturated fat on postprandial lipemia and hemostatic activity. Atherosclerosis. 103:1993;1-11.
17. Nimpf J, Malle E, Leopold B, Wurm H, Kostner GM. Postprandial hyperlipemia inhibits platelet aggregation without affecting prostanoid metabolism. Prostaglandins Leukotrienes Essent Fatty Acids. 37:1989;7-13.
18. Karpe F, Steiner G, Olivecrona T, Carlson LA, Hamsten A. Metabolism of triglyceride-rich lipoproteins during alimentary lipemia. J Clin Invest. 91:1993;748-758.
19. Karpe F. Effects of diet on postprandial lipaemia: suggestion for methodological standardization. Nutr Metab Cardiovasc Dis. 7:1997;44-55.
20. Beck O, Wallén NH, Bröijersén A, Larsson PT, Hjemdahl P. On the accurate determination of serotonin in human plasma. Biochem Biophys Res Commun. 196:1993;260-266.
21. Goodall AH Platelet activation during preparation and storage of concentrates: detection by flow cytometry. Blood Coagul Fibrinolysis. 2:1991;377-382.
22. Janes SL, Wilson DJ, Chronos NAF, Goodall AH. Evaluation of whole blood flow cytometric detection of platelet bound fibrinogen on normal subjects and patients with activated platelets. Thromb Haemost. 70:1993;659-666.
23. Warkentin TE, Powling MJ, Hardisty RM. Measurement of fibrinogen binding to platelets in whole blood by flow cytometry: a micromethod for the detection of platelet activation. Br J Haematol. 76:1990;387-394.
24. Hornstra G, Ten Hoor F. The Filtragometer: a new device for measuring platelet aggregation in venous blood of man. Thromb Diath Haemorrh. 34:1975;531-544.
25. Carlson K. Lipoprotein fractionation. J Clin Pathol. 5:1973;32-37.
26. Zlatkis A, Zak B, Boyle A. A new method for direct determination of serum cholesterol. J Lab Clin Invest. 41:1953;486-492.
27. Fletcher M. A colorimetric method for estimating serum triglycerides. Clin Chim Acta. 22:1968;393-397.
28. Carlson LA. Determination of serum triglycerides. J Atheroscler Res. 3:1963;334-336.
29. Karpe F, Hamsten A. Determination of apolipoproteins B-48 and B-100 in triglyceride-rich lipoproteins by analytical SDS-PAGE. J Lipid Res. 35:1994;1311-1317.
30. Niewiarowski S. Secreted platelet proteins. Bloom AL, Forbes CD, Thomas DP, Tuddenham EGD Haemostasis and Thrombosis. 1994;167-181 Churchill Livingstone, Edinburgh.
31. Larsen E, Celi A, Gilbert GE et al. PADGEM protein: a receptor that mediates the interaction of activated platelets with neutrophils and monocytes. Cell. 59:1989;305-312.
32. Celi A, Pellegrini G, Lorenzet R et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA. 91:1994;8767-8771.
33. Janes SL, Goodall AH. Flow cytometric detection of circulating activated platelets and hyper-responsiveness in pre-eclampsia and pregnany. Clin Sci. 86:1994;731-739.
34. 2. Arterioscler Thromb Vasc Biol. 15:1995;1131-1138.
35. Naseem KM, Goodall AH, Bruckdorfer KR. Differential effects of native and oxidatively modified low-density lipoproteins on platelet function. Platelets. 8:1997;163-173.
36. Lechleitner M, Hoppichler F, Föger B, Patsch JR. Low density lipoproteins of the postprandial state induce cellular cholesteryl ester accumulation in macrophages. Arterioscler Thromb. 14:1994;1799-1807.
37. Patel KD, Zimmerman GA, Prescott SM, McEver RP, McIntyre TM. Oxygen radicals induce human endothelial cells to express GMP-140 and bind neutrophils. J Cell Biol. 112:1991;749-759.
38. Lehr HA, Olofsson M, Carew TE et al. P-Selectin mediates the interaction of circulating leucocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 71:1994;380-386.
39. Gebuhrer V, Murphy JF, Bordet JC, Reck M-P, McGregor JL. Oxidized low-density lipoprotein induces the expression of P-selectin (GMP140/PADGEM/CD62) on human endothelial cells. Biochem J. 306:1995;293-298.
40. Janes SL, Wilson DJ, Cox AD, Chronos NAF, Goodall AH. ADP causes partial degranulation of platelets in the absense of aggregation. Br. J. Haematology. 86:1994;568-573.
41. Bisovsky S, Richter H, Fitscha P, O'Grady J, Sinzinger H. Postprandial hyperlipidemia does not inhibit platelet aggregation. Prostaglandins Leukotrienes Essent Fatty Acids. 47:1992;331-332.
42. 2 formation on close contact of human platelets in media with a low concentration of ionised calcium. Blood. 70:1987;647-651.
43. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphosphate-induced platelet α-granule release. Blood. 82:1993;505-512.
44. Chronos NAF, Wilson DJ, Janes SL, Hutton RA, Buller NP, Goodall AH. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of α-granules or lysosomes from, human platelets. Clin Sci. 87:1994;575-580.